Ken‐ichirou Morishige

3.0k total citations
90 papers, 2.4k citations indexed

About

Ken‐ichirou Morishige is a scholar working on Molecular Biology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Ken‐ichirou Morishige has authored 90 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 34 papers in Reproductive Medicine and 31 papers in Obstetrics and Gynecology. Recurrent topics in Ken‐ichirou Morishige's work include Ovarian cancer diagnosis and treatment (25 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Uterine Myomas and Treatments (15 papers). Ken‐ichirou Morishige is often cited by papers focused on Ovarian cancer diagnosis and treatment (25 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Uterine Myomas and Treatments (15 papers). Ken‐ichirou Morishige collaborates with scholars based in Japan, United States and France. Ken‐ichirou Morishige's co-authors include Kenjiro Sawada, Hirohisa Kurachi, Seiji Mabuchi, Yuji Murata, Yoshihisa Kurachi, Naohiko Takahashi, Kae Hashimoto, Tadashi Kimura, Keiichi Tasaka and Tadashi Kimura and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Ken‐ichirou Morishige

89 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken‐ichirou Morishige Japan 27 1.2k 509 437 344 329 90 2.4k
Cheng‐Han Lee Canada 36 1.1k 1.0× 569 1.1× 966 2.2× 457 1.3× 195 0.6× 81 3.2k
Seiji Nomura Japan 27 624 0.5× 226 0.4× 338 0.8× 556 1.6× 195 0.6× 98 2.2k
Yoshiro Otsuki Japan 23 834 0.7× 291 0.6× 151 0.3× 303 0.9× 79 0.2× 130 1.7k
Patrice Rodien France 32 1.2k 1.0× 445 0.9× 75 0.2× 393 1.1× 243 0.7× 107 3.6k
Anna Spada Italy 46 2.6k 2.2× 280 0.6× 140 0.3× 600 1.7× 445 1.4× 172 7.0k
Stephen Lee United States 26 948 0.8× 131 0.3× 59 0.1× 186 0.5× 466 1.4× 80 2.8k
Bethel Stannard United States 31 2.3k 1.9× 180 0.4× 45 0.1× 321 0.9× 193 0.6× 49 4.1k
Steven E. Scherer United States 19 906 0.8× 81 0.2× 83 0.2× 247 0.7× 83 0.3× 37 1.9k
Joanne Bruno United States 11 2.0k 1.7× 54 0.1× 65 0.1× 343 1.0× 411 1.2× 12 3.1k
Peter A. Cattini Canada 32 2.0k 1.7× 44 0.1× 214 0.5× 139 0.4× 109 0.3× 130 3.3k

Countries citing papers authored by Ken‐ichirou Morishige

Since Specialization
Citations

This map shows the geographic impact of Ken‐ichirou Morishige's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichirou Morishige with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichirou Morishige more than expected).

Fields of papers citing papers by Ken‐ichirou Morishige

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐ichirou Morishige. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichirou Morishige. The network helps show where Ken‐ichirou Morishige may publish in the future.

Co-authorship network of co-authors of Ken‐ichirou Morishige

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichirou Morishige. A scholar is included among the top collaborators of Ken‐ichirou Morishige based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichirou Morishige. Ken‐ichirou Morishige is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawaguchi, Masaya, Hiroki Kato, Yoshifumi Noda, et al.. (2021). CT and MRI characteristics of ovarian mature teratoma in patients with anti-N-methyl-D-aspartate receptor encephalitis. Diagnostic and Interventional Imaging. 102(7-8). 447–453. 5 indexed citations
2.
Kato, Hiroki, Yuichiro Hatano, Masaya Kawaguchi, et al.. (2020). Can MRI features differentiate ovarian mucinous carcinoma from mucinous borderline tumor?. European Journal of Radiology. 132. 109281–109281. 7 indexed citations
3.
Harada, Miyuki, Chisato Kunitomi, Gentaro Izumi, et al.. (2019). A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients. Journal of obstetrics and gynaecology research. 45(10). 2021–2028. 16 indexed citations
4.
Ando, Tomohiro, Hiroki Kato, Tatsuro Furui, et al.. (2018). Uterine smooth muscle tumours with hyperintense area on T 1 weighted images: differentiation between leiomyosarcomas and leiomyomas. British Journal of Radiology. 91(1084). 20170767–20170767. 16 indexed citations
5.
Nakamura, Koji, Kenjiro Sawada, Yasuto Kinose, et al.. (2016). Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells. Molecular Cancer Research. 15(1). 78–92. 183 indexed citations
6.
Nagasawa, Hideko, et al.. (2015). The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer. Biochemical and Biophysical Research Communications. 457(4). 706–711. 20 indexed citations
7.
Kinose, Yasuto, Kenjiro Sawada, Hiroshi Makino, et al.. (2015). IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment. Molecular Cancer Therapeutics. 14(4). 909–919. 23 indexed citations
8.
Kato, Hiroki, Xiangrong Zhou, Takeshi Hara, et al.. (2015). Magnetic resonance imaging of uterine fibroids: a preliminary investigation into the usefulness of 3D-rendered images for surgical planning. SpringerPlus. 4(1). 384–384. 17 indexed citations
9.
Mabuchi, Seiji, Fumiaki Isohashi, Yasuo Yoshioka, et al.. (2010). Prognostic Factors for Survival in Patients With Recurrent Cervical Cancer Previously Treated With Radiotherapy. International Journal of Gynecological Cancer. 20(5). 834–840. 52 indexed citations
10.
Mabuchi, Seiji, Fumiaki Isohashi, Yasuo Yoshioka, et al.. (2010). Concurrent Weekly Nedaplatin, External Beam Radiotherapy and High-Dose-Rate Brachytherapy in Patients with FIGO Stage IIIb Cervical Cancer: A Comparison with a Cohort Treated by Radiotherapy Alone. Gynecologic and Obstetric Investigation. 69(4). 224–232. 27 indexed citations
11.
Mabuchi, Seiji, Ken‐ichirou Morishige, & Tadashi Kimura. (2009). Use of monoclonal antibodies in the treatment of ovarian cancer. Current Opinion in Obstetrics & Gynecology. 22(1). 3–8. 8 indexed citations
12.
Ogata, Seiji, Ken‐ichirou Morishige, Kenjiro Sawada, et al.. (2009). Fasudil Inhibits Lysophosphatidic Acid-Induced Invasiveness of Human Ovarian Cancer Cells. International Journal of Gynecological Cancer. 19(9). 1473–1480. 40 indexed citations
13.
Takeda, Takashi, et al.. (2008). Elevated level of plasma vascular endothelial growth factor after gonadotropin-releasing hormone agonist treatment for leiomyomata. Gynecological Endocrinology. 24(12). 724–726. 2 indexed citations
14.
Hashimoto, Kae, Ken‐ichirou Morishige, Kenjiro Sawada, et al.. (2007). Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo. Biochemical and Biophysical Research Communications. 356(1). 72–77. 10 indexed citations
15.
Morishige, Ken‐ichirou, Toshiya Yamamoto, Kenjiro Sawada, et al.. (2003). Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT. Archives of Gynecology and Obstetrics. 268(2). 105–106. 1 indexed citations
16.
Takeda, Takashi, Hirohisa Kurachi, Toshiya Yamamoto, et al.. (1997). Alternative Signaling Mechanism of Leukemia Inhibitory Factor Responsiveness in a Differentiating Embryonal Carcinoma Cell. Endocrinology. 138(7). 2689–2696. 10 indexed citations
17.
Kurachi, Hirohisa, Hiroshi Adachi, Ken‐ichirou Morishige, et al.. (1996). Transforming growth factor-α promotes tumor markers secretion from human ovarian cancers in vitro. Cancer. 78(5). 1049–1054. 10 indexed citations
18.
Kurachi, Hirohisa, Ken‐ichirou Morishige, Hiroshi Adachi, et al.. (1994). Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF. Cancer. 74(11). 2984–2990. 9 indexed citations
19.
Koyama, Hidekazu, et al.. (1994). Molecular cloning, functional expression and localization of a novel inward rectifier potassium channel in the rat brain. FEBS Letters. 341(2-3). 303–307. 109 indexed citations
20.
Morishige, Ken‐ichirou, Naohiko Takahashi, Ian Findlay, et al.. (1993). Molecular cloning, functional expression and localization of an inward rectifier potassium channel in the mouse brain. FEBS Letters. 336(3). 375–380. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026